Showing 1 - 3 results of 3 for search 'Rapee Trichavaroj', query time: 0.01s
Refine Results
-
1
Exploring potential drug−drug interactions between masculinizing hormone therapy and oral pre‐exposure prophylaxis (F/TDF and F/TAF) among transgender men (iMACT study): a randomiz... by Akarin Hiransuthikul, Narukjaporn Thammajaruk, Stephen Kerr, Rena Janamnuaysook, Siriporn Nonenoy, Piranun Hongchookiat, Rapee Trichavaroj, Yardpiroon Tawon, Jakkrapatara Boonruang, Nipat Teeratakulpisarn, Tim R. Cressey, Peter L. Anderson, Nittaya Phanuphak, the iMACT study team
Published 2025-04-01Get full text
Article -
2
No significant drug−drug interaction between oral TAF‐based PrEP and feminizing hormone therapy among transgender women in Thailand: the iFACT‐3 study by Akarin Hiransuthikul, Narukjaporn Thammajaruk, Stephen Kerr, Rena Janamnuaysook, Siriporn Nonenoy, Piranun Hongchookiat, Rapee Trichavaroj, Yardpiroon Tawon, Jakkrapatara Boonruang, Nipat Teeratakulpisarn, Tim R. Cressey, Peter L. Anderson, Nittaya Phanuphak, the iFACT3 study team
Published 2025-05-01Get full text
Article -
3
Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. by Jintanat Ananworanich, Alexandra Schuetz, Claire Vandergeeten, Irini Sereti, Mark de Souza, Rungsun Rerknimitr, Robin Dewar, Mary Marovich, Frits van Griensven, Rafick Sekaly, Suteeraporn Pinyakorn, Nittaya Phanuphak, Rapee Trichavaroj, Wiriya Rutvisuttinunt, Nitiya Chomchey, Robert Paris, Sheila Peel, Victor Valcour, Frank Maldarelli, Nicolas Chomont, Nelson Michael, Praphan Phanuphak, Jerome H Kim, RV254/SEARCH 010 Study Group
Published 2012-01-01Get full text
Article